Search results
Results from the WOW.Com Content Network
[1] [2] [3] Its purpose under the statute is "to advance the study of the use of cannabis and cannabis derivatives for the treatment of certain medical conditions and diseases". [4] The legislation requires the university to apply to the U..S. Drug Enforcement Administration for licenses to grow and administer medical cannabis. [5]
Research on the medical benefits of cannabis has been hindered by various federal regulations, including its Schedule I classification. [3] To conduct research on cannabis, approval must be obtained from the Food and Drug Administration, [4] and a license must be obtained from the Drug Enforcement Administration specific to Schedule I drugs. [5]
A new study found evidence that marijuana could potentially be used to fight skin cancer, slowing the disease’s growth and killing cancerous cells before they have a chance to spread. But the ...
HIIMR was officially established as a marijuana research institute in 2012, during a time of evolving laws and perceptions of marijuana. HIIMR is intended to be a statewide center of policy and research on marijuana, providing information and expertise for policy makers, health care and medical professionals, business and the media.
Using marijuana daily for years may raise the overall risk of head and neck cancers three- to five-fold, according to a new study that analyzed millions of medical records. “Our research shows ...
For premium support please call: 800-290-4726 more ways to reach us
Curaleaf was founded in 2010 under the name PalliaTech. [1] It operated in New Jersey and had a research center in Colorado. In 2013, the investment group Sputnik purchased a 35% stake in the company. [2] The company name was changed to Curaleaf in 2018, [3] just prior to going public on Toronto's Canadian Securities Exchange under the symbol ...
Cancer Research UK say that while cannabis is being studied for therapeutic potential, "claims that there is solid "proof" that cannabis or cannabinoids can cure cancer is highly misleading to patients and their families, and builds a false picture of the state of progress in this area". [156]